The order will open the door for more research into psychedelic drugs, including ibogaine, sources told CBS News earlier this week.

As the use of these drugs expands, so does research on how they affect a person’s well-being beyond their metabolism, including their mental health. In a study that looked at electronic health records in Sweden from a cohort of more than 95,

Regarding the April 20 editorial “Corporate welfare for hospitals is raising health care costs”: There are many commonsense, bipartisan ways to reduce the cost of health care in the U.S. but cutting the 340B drug pricing program is not one of them.